MGMT and neoplasm: However, tumor O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status is considered a prognostic factor, and an obstacle that cannot be overcome by the initial induction therapy and 6 subsequent cycles (C) of maintenance treatment with TMZ [8, 9].